C-Bond Systems Expands Exclusive Distribution Agreement with Quip Laboratories to Include Vimoba Tablets, Approved for Use Against SARS-CoV-2
17 févr. 2022 08h30 HE
|
C-Bond Systems
HOUSTON, Feb. 17, 2022 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc. (“C-Bond” or “Company”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has expanded its exclusive...